BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

690 related articles for article (PubMed ID: 1863645)

  • 1. Tuberculosis in HIV infection.
    Horner PJ; Moss FM
    Int J STD AIDS; 1991; 2(3):162-7. PubMed ID: 1863645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tuberculosis and human immunodeficiency virus infection in developing countries.
    Harries AD
    Lancet; 1990 Feb; 335(8686):387-90. PubMed ID: 1968123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of the HIV epidemic on tuberculosis control programmes in developing countries.
    Veeken H; Bermejo A
    Trop Doct; 1992 Apr; 22(2):64-7. PubMed ID: 1344023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tuberculosis recurrence in Africa: true relapse or re-infection?
    Daley CL
    Lancet; 1993 Sep; 342(8874):756-7. PubMed ID: 8103871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical features of tuberculosis associated with HIV infection in Taiwan.
    Hsieh SM; Hung CC; Chen MY; Chang SC; Hsueh PR; Luh KT; Chuang CY
    J Formos Med Assoc; 1996 Dec; 95(12):923-8. PubMed ID: 9000809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiretroviral drugs for tuberculosis control in the era of HIV/AIDS.
    Williams BG; Dye C
    Science; 2003 Sep; 301(5639):1535-7. PubMed ID: 12920302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An epidemiological study of tuberculosis and HIV infection in Tanzania, 1991-1993.
    Chum HJ; O'Brien RJ; Chonde TM; Graf P; Rieder HL
    AIDS; 1996 Mar; 10(3):299-309. PubMed ID: 8882670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of BCG vaccine in the prevention and control of tuberculosis in the United States. A joint statement by the Advisory Council for the Elimination of Tuberculosis and the Advisory Committee on Immunization Practices.
    MMWR Recomm Rep; 1996 Apr; 45(RR-4):1-18. PubMed ID: 8602127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of clinical features in tuberculosis associated with infection with human immunodeficiency viruses 1 and 2.
    Gnaore E; Sassan-Morokro M; Kassim S; Ackah A; Yesso G; Adjorlolo G; Digbeu H; Coulibaly D; Coulibaly IM; Doorly R
    Trans R Soc Trop Med Hyg; 1993; 87(1):57-9. PubMed ID: 8385370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chest radiography and beta-2-microglobulin levels in HIV-seronegative and HIV-seropositive African patients with pulmonary tuberculosis.
    Richter C; Pallangyo KJ; Ndosi BN; Chum HJ; Swai AB; Shao J
    Trop Geogr Med; 1994; 46(5):283-7. PubMed ID: 7855913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modelling the economic benefits of tuberculosis preventive therapy for people with HIV: the example of Zambia.
    Foster S; Godfrey-Faussett P; Porter J
    AIDS; 1997 Jun; 11(7):919-25. PubMed ID: 9189218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical course of human immunodeficiency virus type 1 associated pulmonary tuberculosis during short-course antituberculosis therapy.
    Schwander SK; Dietrich M; Mugyenyi P; Kityo C; Okwera A; Johnson J; Nsubuga P; Ruesch-Gerdes S; Whalen C
    East Afr Med J; 1997 Sep; 74(9):543-8. PubMed ID: 9487427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tuberculin sensitivity and HIV-1 status of patients attending a sexually transmitted diseases clinic in Lusaka, Zambia: a cross-sectional study.
    Duncan LE; Elliott AM; Hayes RJ; Hira SK; Tembo G; Mumba GT; Ebrahim SH; Quigley M; Pobee JO; McAdam KP
    Trans R Soc Trop Med Hyg; 1995; 89(1):37-40. PubMed ID: 7747304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tuberculosis and HIV-infection in developing countries.
    Broekmans JF
    Trop Geogr Med; 1991 Jul; 43(3):S13-21. PubMed ID: 1687768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive markers of survival in HIV-seropositive and HIV-seronegative Tanzanian patients with extrapulmonary tuberculosis.
    Richter C; Koelemay MJ; Swai AB; Perenboom R; Mwakyusa DH; Oosting J
    Tuber Lung Dis; 1995 Dec; 76(6):510-7. PubMed ID: 8593371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Tuberculosis and the HIV pandemic. Risk of nosocomial tuberculosis infection].
    Pedersen C; Kolmos HJ; Nielsen JO
    Ugeskr Laeger; 1997 Feb; 159(9):1233-8. PubMed ID: 9072866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening for active tuberculosis in HIV testing centre.
    Espinal MA; Reingold AL; Koenig E; Lavandera M; Sanchez S
    Lancet; 1995 Apr; 345(8954):890-3. PubMed ID: 7707812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spectrum of immunodeficiency in HIV-1-infected patients with pulmonary tuberculosis in Zaire.
    Mukadi Y; Perriƫns JH; St Louis ME; Brown C; Prignot J; Willame JC; Pouthier F; Kaboto M; Ryder RW; Portaels F
    Lancet; 1993 Jul; 342(8864):143-6. PubMed ID: 8101257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV infection in patients with tuberculosis in Kinshasa, Zaire.
    Colebunders RL; Ryder RW; Nzilambi N; Dikilu K; Willame JC; Kaboto M; Bagala N; Jeugmans J; Muepu K; Francis HL
    Am Rev Respir Dis; 1989 May; 139(5):1082-5. PubMed ID: 2496632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tuberculosis and HIV infection association in a rural district of northern Uganda: epidemiological and clinical considerations.
    Migliori GB; Borghesi A; Adriko C; Manfrin V; Okware S; Naamara W; Bartoloni A; Neri M; Acocella G
    Tuber Lung Dis; 1992 Oct; 73(5):285-90. PubMed ID: 1493236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.